Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination
about
Booster dose vaccination for preventing hepatitis BEmerging hepatitis B virus infection in vaccinated populations: a rising concern?The clinical implications of hepatitis B virus genotypes and HBeAg in pediatricsHepatitis B and the need for a booster doseVisiting sick people: is it really detrimental to our health?Gender difference of alanine aminotransferase elevation may be associated with higher hemoglobin levels among male adolescents.Hepatitis B virus: where do we stand and what is the next step for eradication?Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedulesAge-specific prevalence of hepatitis B virus infection in young pregnant women, Hong Kong Special Administrative Region of China.Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial.Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.Seroprevalence of hepatitis B virus among adults at high risk for HIV transmission two decades after implementation of nationwide hepatitis B virus vaccination program in Taiwan.HBV vaccine efficacy and detection and genotyping of vaccineé asymptomatic breakthrough HBV infection in Egypt.Let It "B"? The role of Hepatitis B universal vaccination among italian problematic drug users.High Risk of Hepatitis B Reactivation among Patients with Acute Myeloid LeukemiaActive-passive Immunization Effectiveness Against Hepatitis B Virus in Children Born to HBsAg Positive Mothers in Amol, North of Iran.Effectiveness of hepatitis B virus vaccination program in Egypt: Multicenter national project.CD4+ T Cells Are Not Required for Suppression of Hepatitis B Virus Replication in the Liver of Vaccinated Chimpanzees.Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers.Absence of occult hepatitis B virus infection in sera of diabetic children and adolescents following hepatitis B vaccinationImmune persistence after hepatitis B vaccination in infancy - Fact or fancy?Antibody and immune memory persistence post infant hepatitis B vaccination.Immunogenicity of Recombinant Hepatitis B Vaccine Among Routinely Vaccinated Healthy and Chronically Ill Children in Assiut, Upper EgyptThe hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity.Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand.Antibody levels against hepatitis B virus after hepatitis B vaccination in Egyptian diabetic children and adolescents.Serum levels of anti-hepatitis B surface antibody among vaccinated population aged 1 to 18 years in ahvaz city southwest of iran.Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine.A Single Center Analysis of the Positivity of Hepatitis B Antibody after Neonatal Vaccination Program in Korea.Review of a new fully liquid, hexavalent vaccine: Hexaxim.Immune responses to hepatitis B immunization 10-18 years after primary vaccination: a population-based cohort study.Prevalence of anti-hepatitis B surface antibodies among children and adolescents vaccinated in infancy and effect of booster dose administered within a pilot study.Persistence of protection of hepatitis B vaccine and response to booster immunization in 2- to 12-year-old children.Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.Long-term persistence of immunity after hepatitis B vaccination: Is this substantiated by the literature?Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.Vertical transmission of hepatitis B virus during pregnancy and delivery in Denmark.Impact and long-term protection of hepatitis B vaccination: 17 years after universal hepatitis B vaccination in Tunisia.Nosocomial outbreak of hepatitis B virus infection in a pediatric hematology and oncology unit in South Africa: Epidemiological investigation and measures to prevent further transmission.
P2860
Q24236587-ABEAF8F4-784D-4363-A988-6B39345B16C8Q27012663-FCA9D381-AB03-4780-8D71-6E8B9704E063Q28073299-3575A8ED-93C6-4D48-AE34-10147D8DAA97Q28239937-5BF4B179-799F-4B4E-BECA-8B8BC78119FAQ33340234-4D1A4828-209A-4326-8A6F-C71DE0215C0BQ33725657-1B16447A-F717-47C3-90B5-2D13138FEB73Q33958764-DC5B13DD-D897-429C-A7C3-D62FF8583F84Q34021203-9AF6545F-8115-46A3-90FA-6DB8237FB1A0Q34460388-EF6EC160-3A9E-45AB-BD2E-591AB5FD2776Q34581747-39EF0972-E5CB-43D9-B33C-4E314125E366Q34789906-5E0055DE-6CA1-4DE6-AF91-EFF590CFC0A0Q35055166-7BA5C0EF-8F7B-4892-84AC-8760595710F0Q35108823-AFC1D51E-320C-41A9-8738-DD0E7FF17A41Q35174813-B172ACCB-918F-4B00-8FBC-EE5E533C05C0Q35539786-81664A31-CB12-4044-AF61-47A0B61C8947Q35606765-FE64AAFA-6705-4C4C-A66F-131D37D72DF2Q35651596-FBAB689F-FBA5-43AB-9E75-7C8045314179Q36138640-3AF47615-A569-4848-BFB3-33E7098A313AQ36365279-B4E3DDE6-E80A-4C44-81B3-BBB7AB725BEBQ36391894-5A80043A-2570-4BB8-B891-B0525420D155Q36978317-3D025C16-4C0D-4760-B869-FDEAF2260A5DQ37131019-1AB01D31-5DFA-4056-81E8-50937DA8454DQ37216022-7B84E62C-D8B7-4981-BEE2-2577BCC83F71Q37292882-7293822E-9BD9-43C8-8EC8-1CDBB75039B9Q37448838-61E3D7BC-8DC5-4451-9303-10D089E4D230Q37530077-EC85DBEA-3BF7-4D9D-A144-5A6A33B6923EQ37530407-CC00EDFE-FDCE-4B45-9C37-EFAA731FA1F3Q37540487-21B0FD2D-418D-4AE8-950A-4E2A8019DFA5Q37605957-E4A14CF5-1479-4878-966C-0905700C1F66Q37740476-92644164-7927-4CD8-BF62-FF56D479D760Q38084695-4D1AC23C-095A-4A85-A9F8-BBC215839B7BQ39812218-76B1F509-178D-4223-98F7-EC755927F672Q40042775-BEA01751-F755-4294-A207-D4C96A6EADD2Q40057020-6D025418-B80B-4573-A365-79FD6F9DF8F1Q40143078-D4A049EE-52CC-4F69-8C4E-7F39336A86F3Q40300417-D91A022A-049F-482D-90CC-18775D218BC2Q40440788-D23A4A04-1863-4B08-BA20-A33A2F5755B4Q40475167-179E8CA2-A0FF-44D9-B285-AB660067DB15Q40571829-3E48B28D-4412-4DEC-84D6-B23C6359723EQ41182375-706B5BD3-B70B-4C76-AA6E-4AF5F2A026F6
P2860
Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination
description
im Dezember 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 December 2004
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2004
@uk
name
Waning immunity to plasma-deri ...... ars after neonatal vaccination
@en
Waning immunity to plasma-deri ...... ars after neonatal vaccination
@nl
type
label
Waning immunity to plasma-deri ...... ars after neonatal vaccination
@en
Waning immunity to plasma-deri ...... ars after neonatal vaccination
@nl
prefLabel
Waning immunity to plasma-deri ...... ars after neonatal vaccination
@en
Waning immunity to plasma-deri ...... ars after neonatal vaccination
@nl
P50
P356
P1433
P1476
Waning immunity to plasma-deri ...... ars after neonatal vaccination
@en
P2093
Hsu-Mei Hsu
Wei-Kuang Chi
P304
P356
10.1002/HEP.20490
P407
P577
2004-12-01T00:00:00Z